Scholars@Duke publication: Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.

Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.

Publication , Journal Article

Bose, S; Robles, J; McCall, CM; Lagoo, AS; Wechsler, DS; Schooler, GR; Van Mater, D

Published in: Pediatr Blood Cancer

January 2019

Published version (DOI) Link to item

Duke Scholars

Author David Sinclaire Van Mater Pediatrics, Hematology-Oncology

Author Anand Shreeram Lagoo Pathology

Author Chad Michael McCall Pathology

Published In

Pediatr Blood Cancer

DOI

10.1002/pbc.27491

EISSN

1545-5017

Publication Date

January 2019

Volume

Issue

Start / End Page

e27491

Location

United States

Related Subject Headings

Remission Induction
Prognosis
Oncology & Carcinogenesis
Nivolumab
Humans
Histiocytic Sarcoma
Female
Bone Neoplasms
Antineoplastic Agents, Immunological
Adolescent

Citation

APA

Chicago

ICMJE

MLA

NLM

Bose, S., Robles, J., McCall, C. M., Lagoo, A. S., Wechsler, D. S., Schooler, G. R., & Van Mater, D. (2019). Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma. Pediatr Blood Cancer, 66(1), e27491. https://doi.org/10.1002/pbc.27491

Bose, Shree, Joanna Robles, Chad M. McCall, Anand S. Lagoo, Daniel S. Wechsler, Gary R. Schooler, and David Van Mater. “Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.” Pediatr Blood Cancer 66, no. 1 (January 2019): e27491. https://doi.org/10.1002/pbc.27491.

Bose S, Robles J, McCall CM, Lagoo AS, Wechsler DS, Schooler GR, et al. Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma. Pediatr Blood Cancer. 2019 Jan;66(1):e27491.

Bose, Shree, et al. “Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.” Pediatr Blood Cancer, vol. 66, no. 1, Jan. 2019, p. e27491. Pubmed, doi:10.1002/pbc.27491.

Bose S, Robles J, McCall CM, Lagoo AS, Wechsler DS, Schooler GR, Van Mater D. Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma. Pediatr Blood Cancer. 2019 Jan;66(1):e27491.

Published In

Pediatr Blood Cancer

DOI

10.1002/pbc.27491

EISSN

1545-5017

Publication Date

January 2019

Volume

Issue

Start / End Page

e27491

Location

United States

Related Subject Headings

Remission Induction
Prognosis
Oncology & Carcinogenesis
Nivolumab
Humans
Histiocytic Sarcoma
Female
Bone Neoplasms
Antineoplastic Agents, Immunological
Adolescent